Cannabis Report
Lithium
Home > Boards > US Listed > Medical - Drugs >

Moleculin Biotech (MBRX)

MBRX RSS Feed 		Add MBRX Price Alert      Hide Sticky   Hide Intro
Moderator: Dennisb68, king oil
Search This Board: 
Last Post: 8/17/2018 2:47:08 PM - Followers: 41 - Board type: Free - Posts Today: 0

wally

WALTER V. KLEMP
President, CEO and Chairman

Company web. site  http://www.moleculin.com
   
Authorized Shares        75,000,000 as of  03/01.2018
Outstanding Shares     24,768,861 as of   03/01/2018

Moleculin receives approval for leukemia clinical trial; shares ahead 23% premarket
https://seekingalpha.com/news/3365150-moleculin-receives-approval-leukemia-clinical-trial-shares-ahead-23-percent-premarket

Moleculin Targets accelerated FDA approval of WP1732; Pursues Development for Ocular Tumors
https://ir.moleculin.com/press-releases/detail/89/moleculin-targets-accelerated-fda-approval-of-wp1732
 Moleculin Announces Engagement with Voisin Consulting Life Sciences to Expand Annamycin Clinical Trial
https://globenewswire.com/news-release/2018/05/03/1495957/0/en/Moleculin-Announces-Engagement-with-Voisin-Consulting-Life-Sciences-to-Expand-Annamycin-Clinical-Trial.html

Moleculin Enters Agreement with Seidman Cancer Center to Conduct Leukemia Clinical Trials
https://finance.yahoo.com/news/moleculin-enters-agreement-seidman-cancer-123000495.html

Moleculin Announces Grant-Funded Collaboration to Expand Understanding of New Discovery
http://www.marketwired.com/press-release/moleculin-announces-grant-funded-collaboration-expand-understanding-new-discovery-2246407.htm

Exclusive: Moleculin CEO Says Acute Myeloid Leukemia Candidate Could Be 'Remarkable' https://www.benzinga.com/general/biotech/18/03/11260689/exclusive-moleculin-ceo-says-acute-myeloid-leukemia-candidate-could-b

 

Moleculin Biotech (MBRX) Buys Active Drug Compound for Treatment of Brain Cancer https://www.streetinsider.com/Corporate+News/Moleculin+Biotech+%28MBRX%29+Buys+Active+Drug+Compound+for+Treatment+of+Brain+Cancer/13211319.html




Moleculin Biotech, Inc. (Nasdaq: MBRX) to Ring The Nasdaq Stock Market Closing Bell in celebration of IPO

Metabasis Therapeutics (NASDAQ:MBRX)
Historical Stock Chart

Moleculin Biotech (Nasdaq:MBRX), a preclinical and clinical-stage pharmaceutical company focused on the development of anti-cancer drug candidates, will visit the Nasdaq MarketSite in Times Square to celebrate its initial public offering (IPO).

In honor of the occasion, Walter Klemp, Chief Executive Officer, will ring the Closing Bell.

Where:
Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio

When:
Thursday, June 2, 2016 – 3:45 p.m. to 4:00 p.m. ET

Moleculin Biotech Media Contact:
Sean Leous
(646) 863-8998
sleous@pcgadvisory.com
Cannabis Report
Lithium
MBRX
Current Price
Volume:
Bid Ask Day's Range
MBRX Detailed Quote
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
MBRX News: Moleculin Biotech, Inc. Reports Financial Results for the Second Quarter Ended June 30, 2018 08/13/2018 07:30:00 AM
MBRX News: Current Report Filing (8-k) 08/13/2018 07:25:36 AM
MBRX News: Quarterly Report (10-q) 08/10/2018 04:26:24 PM
MBRX News: Moleculin Seeks Approval from Polish Regulatory Agency for Skin Cancer Clinical Trial 08/09/2018 07:30:00 AM
MBRX News: Moleculin Announces Enrollment Opens for Brain Tumor Trial of WP1066 07/31/2018 07:30:00 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#832  Sticky Note Benzinga Interview of MBRX CEO, this should have ConstitutionNow 03/02/18 08:57:57 AM
#927   You're not batting 1000 here are you? jet101 08/17/18 02:47:08 PM
#926   I sold at a loss. What a junk IPO$ 08/17/18 12:32:45 PM
#925   What about it doesn't look good to you? Dennisb68 08/11/18 03:37:07 PM
#924   Whats up with this POS.. Doesn't look good.. jobilly 08/10/18 11:05:15 AM
#923   Yes. It’s going slower than I thought considering king oil 08/09/18 09:10:47 AM
#922   Anyone else worried about lack of anamycin results? ConstitutionNow 08/08/18 11:21:49 PM
#921   Sure hope you're right. I've been accumulating ConstitutionNow 07/31/18 12:38:34 PM
#920   One day we are going to get a Dennisb68 07/31/18 11:27:43 AM
#919   Actually, the share price is up from the Dennisb68 07/31/18 11:26:38 AM
#918   Moleculin Expands Operations to Australia; Taps R&D Incentive king oil 07/11/18 11:00:45 AM
#917   You should be concerned it looks like it's Redskins88 07/11/18 10:45:32 AM
#916   We need some positive trial results and soon ConstitutionNow 06/27/18 12:15:53 PM
#915   No, I'm not concerned with this drop either. Dennisb68 06/21/18 11:40:39 AM
#914   I am not concerned in the least with stampede1724 06/21/18 10:37:58 AM
#913   It's looking like $1.84 may be the bottom. Dennisb68 06/21/18 10:31:38 AM
#912   I will too. IPO$ 06/21/18 10:02:33 AM
#911   I just picked up another 1000 shares and Dennisb68 06/21/18 10:02:09 AM
#910   Biotechnology stocks are red hot right now. IPO$ 06/21/18 09:58:46 AM
#909   It did the same thing when we had Dennisb68 06/21/18 09:58:05 AM
#908   Is Roth shorting ahead of that offering? IPO$ 06/21/18 09:55:11 AM
#907   Why though? Offering price was $2.10. IPO$ 06/21/18 09:54:25 AM
#906   Taking a hit in pre market on the news. Dennisb68 06/21/18 09:05:44 AM
#905   It certainly settled back down from premarket levels king oil 06/20/18 09:12:13 PM
#904   Looks good but is it another bio-fizzle. mpp1 06/20/18 08:37:01 AM
#903   https://seekingalpha.com/news/3365150-moleculin-receives-approval-leukemia-clini davidsson10 06/20/18 08:22:34 AM
#902   Moleculin Biotech Enters Pact with Polish University to king oil 06/18/18 05:43:32 PM
#901   Difficult to predict. It hit $3.75 very king oil 06/18/18 03:44:11 PM
#900   How high could this stock go? IPO$ 06/18/18 02:29:39 PM
#899   Nice to see it moving higher again. Dennisb68 06/18/18 12:53:11 PM
#898   Looks like the optional reverse split is approved. ConstitutionNow 06/08/18 05:56:41 PM
#897   Moleculin’s Breakthrough Discovery of a New Molecule for king oil 06/07/18 05:07:12 PM
#896   If they presented the data would that be ConstitutionNow 05/26/18 12:08:29 AM
#895   I don't care for the silence no matter RockinTop 05/25/18 11:59:36 AM
#894   Yes. Good catch. Very likely similar to king oil 05/25/18 11:24:04 AM
#893   I believe king oil's suggestion of two parts rcharlev 05/23/18 06:29:41 PM
#892   ah ha... I was looking under keynote speakers... wagthewhale 05/23/18 06:25:35 PM
#891   Yes it does list him. Hover your rcharlev 05/23/18 06:09:33 PM
#890   http://www.gap2018.org <---doesnt show Dr. Priebe as a speaker. smh wagthewhale 05/22/18 12:21:59 PM
#889   Soooo...where is this new data they were suppose ConstitutionNow 05/21/18 11:45:12 AM
#888   Perhaps there are 2 parts for approval, one king oil 05/15/18 12:09:18 PM
#887   So did I according to the announcement I linked. RockinTop 05/15/18 10:58:28 AM
#886   Saw that too, I thought they were approved ConstitutionNow 05/15/18 10:05:33 AM
#885   Seemingly conflicting comments in the latest announcement compared RockinTop 05/15/18 10:02:17 AM
#884   Moleculine presenting new data on WP1066 in Stockholm ConstitutionNow 05/14/18 11:05:27 AM
#883   Just checking in to see where that $8 wagthewhale 05/11/18 11:27:04 AM
#882   Moleculin Announces Engagement with Voisin Consulting Life Sciences king oil 05/04/18 08:15:22 AM
#881   That sound very positive. I still believe current Dennisb68 04/25/18 09:06:51 AM
#880   Moleculin Biotech Enters Pact with BSP Pharmaceuticals for king oil 04/24/18 09:28:29 AM
#879   Moleculin Announces Patients Treated in FDA Approved Phase Dennisb68 04/04/18 10:43:56 AM
#878   Nice to see some buying going into the Dennisb68 04/02/18 04:02:28 PM
PostSubject
© 2018 InvestorsHub.com, Inc.